FindTrial
Sign In

Clinical Pharmacology Study of TS-143 in Hemodialysis and Non-dialysis Chronic Kidney Disease Patients

Clinical Pharmacology Study of TS-143 in Hemodialysis and Non-dialysis Chronic Kidney Disease Patients

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080223328
Enrollment
28
Registered
2016-09-23
Start date
2016-09-23
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease

Interventions

investigational material(s) Generic name etc : TS-143 INN of investigational material : Therapeutic category code : --- Other Dosage and Administration for Investigational material : Oral

Sponsors

Taisho Pharmaceutical co., LTD
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Hemodialysis and Non-dialysis Chronic Kidney Disease Patients - Patients who agree for informed concent with signature etc.

Exclusion criteria

Exclusion criteria: - Complication of malignancy tumor, hepatic disease, allergic reaction etc. - Patient may become pregnant etc.

Design outcomes

Primary

MeasureTime frame
safety, pharmacokinetics and pharmacodynamics—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026